Search the portal
China legal tool Healthcare & life sciences National framework
Interactive China legal orientation tool. Review the result with the relevant legal guide and qualified counsel where facts or local implementation matter.
Qualifying international clinical trials for China drug/device marketing authorization can use filing rather than international-cooperation approval if no HGR material leaves China and the specified collection/testing/analysis/disposal conditions are met. Exploratory research portions still require cooperation approval.
China legal rules often begin with a national framework, while the operational answer can depend on location, dates, documents, status and authority practice. Use this result to structure the next verification step.
Use these checks before treating an automated output as a legal conclusion.
It provides a structured calculation, screening result or drafting aid based on the facts entered and the assumptions stated on this page.
Verify the legal authority, effective date, input data, territorial scope and any exclusions identified in the result.
Documents, disputed facts, local implementation and authority discretion can affect the practical outcome.
Escalate material exposure, disputed facts, imminent deadlines, formal notices or any issue requiring representation or a legal opinion.
Use the output to organize the facts, then confirm the source, evidence, local implementation and available remedy before acting.
